SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dabur, Ayush Ministry launch GLYCODAB Tablets

14 Nov 2017 Evaluate

Dabur India and Ministry of Ayush have joined hands in their fight against the growing menace of Diabetes in India with traditional Ayurveda. As part of its mission to transform the traditional knowledge of Ayurveda into a contemporary healthcare option, Dabur India has launched a revolutionary breakthrough product Dabur GLYCODAB Tablets (AYUSH 82) in partnership with C.C.R.A.S. (Ministry of Ayush, Govt. of India).

Dabur GLYCODAB Tablets will be an advanced product developed for the effective management of Diabetes. The product is backed by several clinical studies and scientific experiments that marks the marriage of traditional Ayurvedic knowledge with modern day science. A clinical study conducted with Madhumeha (Non-Insulin Dependent Diabetes Mellitus, NIDDM), demonstrated that Dabur GLYCODAB Tablets (AYUSH 82) helps reduce fasting and post-prandial blood sugar levels along with a clinical improvement in diabetic subjects after 24 weeks of treatment.

Dabur India is one of the largest FMCG Company in India. Building on a legacy of quality and experience of over 125 years, Dabur operates in key consumer products categories like Hair Care, Oral Care, Health Care, Skin Care, Home Care & Foods.


Dabur India Share Price

476.60 -11.00 (-2.26%)
11-May-2026 10:10 View Price Chart
Peers
Company Name CMP
Hindustan Unilever 2269.25
Godrej Consumer Prod 1022.50
Dabur India 476.60
Colgate Palmol. (I) 2192.95
P&G Hygiene 9833.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×